NA-704™

About Amyotrophic lateral sclerosis (ALS)

Amyotrophic lateral sclerosis is a progressive neurogenerative system disease that affects nerve cells in the brain and spinal cord. Motor neurons reach from the brain to the spinal cord and from the spinal cord to the muscles throughout the body. The progressive degeneration of the motor neurons in ALS eventually leads to their demise.

When the motor neurons die, the ability of the brain to initiate and control muscle movement is lost. When voluntary muscle action is progressively affected, people may lose the ability to speak, eat, move and breathe.

How does NA-704™ work?

Biomed team has developed a new drug, NA-704 which is based on neurogenesis to catalyze the regeneration of new neurons in the hippocampus, thus, to offset the loss of motor neurons in the brain.

NA-704™ is designed to stimulate neurogenesis and reduce muscular spasticity, and rescue the damaged motor neurons.

NA-704 has the following properties:

The Phase 2B clinical trials of NA-704 have been initiated to evaluate its safety and efficacy as required by the US Food and Drug Administration (FDA) and other regulators overseas before being approved for usage and marketing worldwide.